Fred Alger Management, LLC Royalty Pharma PLC Transaction History

Fred Alger Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $3.21 Million - $3.75 Million	-88,810 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $2.41 Million - $2.82 Million	60,510 Added 213.82%	88,810 $3.64 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $17,613 - $21,973	-416 Reduced 1.45%	28,300 $1.23 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $636,000 - $881,280	17,608 Added 158.52%	28,716 $1.44 Million
Q3 2020 Nov 13, 2020	SELL	$38.56 - $48.36 $207,915 - $260,757	-5,392 Reduced 32.68%	11,108 $467,000
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $734,250 - $859,815	16,500 New	16,500 $801,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.